Author Archives: Max Rosett

On March 24, the FDA approved a drug called ipilimumab for the treatment of late stage melanoma. The approval follows the publication of a paper last June that showed ipilimumab to be the first drug ever to provide a statistically significant survival advantage for advanced melanoma patients. By stimulating the immune system, “ipi” (as many »

Like many students, I found last semester’s record number of incidents of alcohol poisoning more than a bit concerning. Yale’s administration has rightly recognized that the consequences are only magnified when students are too scared to get treatment for their friends who find themselves in a compromised state. The resulting policies, with their emphasis on »